• About
  • Meet The Team
  • Privacy Policy
Thursday, March 4, 2021

Stocks Telegraph
  • Login
  • Home
  • Featured
  • Investing
  • Morning News
  • Mid Day Movers
No Result
View All Result
Stocks Telegraph
No Result
View All Result

Miragen Therapeutics (NASDAQ: MGEN) Acquire Viridian Therapeutics

by Hasnain R
October 28, 2020
in Featured, Mid Day Movers
Share on FacebookShare on Twitter

Miragen Therapeutics, Inc. (NASDAQ: MGEN) shares traded up 125.04% during the pre-market trading session after the biotechnology company has announced that it has acquired Viridian Therapeutics, Inc. Miragen believed that this acquisition will create opportunities for the stockholders of Miragen. At the same time, the company has also announced the agreement for the sale of Series A non-voting convertible preferred stock.

Miragen Therapeutics also disclosed that it has signed a sale agreement of a Series A preferred stock with a group of institutional accredited investors directed by Fairmount Funds Management LLC. The other institutional investors include Cormorant Asset Management, Perceptive Advisors, Surveyor Capital Commodore Capital, and Ridgeback Capital, Venrock Healthcare Capital Partners, Wellington Management, Ally Bridge Group, Logos Capital, BVF Partners L.P., as well as additional undisclosed institutional investors.

This private offering will help the company generate a profit of approximately $91 million before subtracting offering and agent expenses. It has disclosed that the profit from the private offering will be used to move forward the clinical studies of VRDN-001.

VRDN-001 is a clinical-stage insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb). VRDN-001 is the important candidate of Miragen Therapeutics used for the treatment of Thyroid eye disease (TED). Miragen anticipates that it will start a Phase II clinical trial of VRDN-001 in TED in 2021.

The global rights to make and commercialize VRDN-001 that do not use radiopharmaceuticals, including TED treatment, were licensed by Veriden of ImmunoGen Inc. As per the agreement, ImmunoGen has got the upfront payment and royalty payments.

Miragen Therapeutics, Inc. (NASDAQ: MGEN) shares were trading up 113.50% at $1.110 during the pre-market trading session of Wednesday. In the pre-market trading session, it has recorded a trading volume of 26.96 million. Miragen Therapeutics, Inc. (MGEN) share price went from a low point around $0.31 to briefly over $2.27 in the past 52 weeks. MGEN market cap has remained high, hitting $29.18 Million at the time of writing.

Get The Best Stocks To Trade Every Day!

Join now to get the Stockstelegraph.com pre-market morning brief 100% free

Tags: AccquisitionMiragen Therapeutics IncNASDAQ: MGENSeries A preferred stockViridian Therapeutics IncVRDN-001

Related Posts

Marinus Pharmaceuticals (NASDAQ: MRNS) Is Popping Today. Here’s Why
Featured

Apple (AAPL) or Alphabet (GOOGL): Which is the Better Stock Pick?

March 1, 2021
ASML Holding (NASDAQ: ASML) Announces 2020 Q3 Results
Featured

What dragged Vistra Corp (VST) about 25% lower?

February 27, 2021
High Flying Plasma Pharmaceuticals as FDA Approves Plasma-based COVID-19 Treatment
Featured

Three Top Coronavirus Stocks to Buy Anytime Soon

February 27, 2021
Tesla Inc. (NASDAQ: TSLA) Reportedly Discuss Nickel Supply Deal With Top Miner BHP
Featured

AMC Entertainment (AMC) Avoids Bankruptcy as Shares Pop Up

January 27, 2021
Top 3 Health Care Stocks that can attract investors in 2021
Featured

Top 3 Health Care Stocks that can attract investors in 2021

January 27, 2021
Sunworks (NASDAQ: SUNW) Stock Is Soaring Today. Here’s Why
Featured

Overstock.com (OSTK) Set to Convert its blockchain-based subsidiary to a limited partnership “Fund”

January 27, 2021
Next Post
Top 20 Banking Industry Stocks For October 2020

10 Apparel Manufacturing Industry Stocks That Can Be Worth Buying

GameStop Corp. (GME) Stock has skyrocketed in the Pre-Market: What’s happening?

Top 3 Reasons Why AzurRx Biopharma Inc [AZRX] is Gaining Bullish Momentum
by ST Staff
February 25, 2021
0

GameStop Corp. (GME) shares have been on a skywalk. The videogame platform seller is captivating the attention in the market...

Read more

Butterfly Network (BFLY): A game changer for medical Imaging devices

Top Performing Stocks Even as Weak Private Payrolls Data Dampens Market Sentiment
by ST Staff
February 24, 2021
0

On January 25, 2011, Jonathan M. Rothberg introduced Butterfly Network (BFLY)‎ that is currently dealing with designing of medical imaging...

Read more

The Three Best Hydrogen Stocks to Watch For in 2021

The Three Best Hydrogen Stocks to Watch For in 2021
by Ali Hassan
February 24, 2021
0

Hydrogen technology is the next big thing that is part of the Go Green movement. In the recent few months,...

Read more

The Three SPAC Stocks to Buy Anytime Soon

by Ali Hassan
February 26, 2021
0

The SPAC stocks have been in action and there are some potential investment opportunities to watch for. A special purpose...

Read more

Early Morning Vibes: Check These 4 Hot Stocks Right Now

GEVO Inc [GEVO]  – A Top Stock To Watch For The Remainder Of 2020
by Hasnain R
February 26, 2021
0

Yesterday the US indices plunged deep into the red again. The last two days have seen a brave recovery, but panic...

Read more
  • About
  • Meet The Team
  • Privacy Policy

© 2020 Stocks Telegraph - All Rights Reserved

No Result
View All Result
  • Home
  • Featured
  • Investing
  • Morning News
  • Mid Day Movers

© 2020 Stocks Telegraph - All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Get The Best Stocks To Trade Every Day!

Join now to get the Stockstelegraph.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.